Pleno Inc.

Our thanks to Gabrielle Mostello of Firstword Healthtech for their article, ‘Pleno raises $25M to grow multi-omics platform under new CEO’. Our new CEO Dr. Vik Vaz, M.D. Vaz is quoted as saying that as a physician he has seen firsthand how patients and laboratories truly need our technology. He adds that he strongly believes it has the potential to make a real difference in patient care and that we cannot waste a moment bringing this to market." Also quoted is our Chairman of the Board, Greg Lucier. Read more here: https://lnkd.in/gAU77ReP

Our thanks to Jared Whitlock, Features Editor at Endpoints News for taking the time to talk with our new CEO, Dr. Vik Vaz, M.D. about his appointment and Series B funding. Read More: https://lnkd.in/d7zyn8SD #multiomics #oncology #infectiousdisease

Today we are pleased to announce that Dr. Vik Vaz M.D. has joined us to lead our next phase of growth as Chief Executive Officer. He brings deep commercial experience in the life sciences and medical technology sectors that prepares us well to scale our commercial operations. Vik is excited about our groundbreaking technology, the compelling data we have already generated and how we will be able to drive advances across oncology, infectious disease and many other clinical applications. Furthermore, we have closed our Series B Funding with current investors Deerfield Management, Foresite Capital and Medical Excellence Capital, remaining committed to supporting the next phase of the company’s growth. 

Yesterday, we took the difficult but necessary step of implementing a furlough that impacted many of our Pleno people. This talented team of passionate, driven, enthusiastic, collaborative people took on a bold vision to create and build innovative technology and have achieved all significant milestones in a very accelerated timeline – an accomplishment they are very proud of. In this challenging funding environment, it became necessary to scale back our operations while remaining committed to our vision.    Our innovative RAPTOR™ instrument platform, with an impressive portfolio of 70+ associated patents covering our biochemistry, instrumentation, software, and reagents is poised for flight.

Today for #FeatureFriday we're turning the spotlight to the people who have joined the Pleno team recently. We're proud to have these new colleagues join us in our mission to design, develop and bring to market a revolutionary instrument platform that transforms methods of multi-omic target detection for a range of impactful applications. Welcome Joana Antunes, PhD, Kameel Abi-Samra, PhD, Lance Held and Mark Wright PhD.! #plenopeople #innovators #engineers #scientists #multiomics

For #FeatureFriday this week, meet Hector Jimenez. Hector's Q&A is one of our favorites yet as he had so much to share. We love his comment that when the results of his experiments help contribute to key decisions for hardware architecture and/or development, it feels like a piece of him goes into the machine! As a Systems Integration Engineer he loves interacting with all the teams here and helping to bring everything together, saying, "it's a very satisfying experience to see our instrument in action after starting out as an idea on a test bed. Every day is an opportunity to integrate and optimize!"   Hector said that he enjoys working at Pleno because it is "full of wonderful people who are willing to help you learn along the way if you put in the effort. He said, "I was more hardware focused in my day-to-day activities in previous roles. But thanks to the culture here, I have been able to expand beyond that and learn more about the chemistry and applications side of things." He added that while he tends to be a more quiet person by nature, the environment here has encouraged him to speak his mind and contribute. Brainstorming sessions at Pleno are a favorite now!     Another favorite is Fridays! To quote Hector about the favorite part of his week or day, "I can say "every day". It's easy to come to work when the work environment is vibrant and the work itself is fulfilling. If I must choose though: Fridays! I look forward to every Friday evening as it is not uncommon to hang out for a bit at the end of the workday after a long week and socialize with everyone. We share weekend plans as well as triumphs and tribulations of the work-week.   Lastly, Hector shared that he is working hard to become quad-lingual! I speak English, Spanish, Korean, and Toki Pona -- in that order of fluency/proficiency.   #plenopeople #team #collaboration #scientists #engineers #innovation

Join our very own Gavin Stone and BioTools Innovator to learn more about product roadmaps in the biotech landscape and how to optimize to avoid common pitfalls. https://lnkd.in/gd3TC7Ah

We are proud to celebrate the incredible accomplishments and contributions of our interns on #NationalInternDay! Throughout the summer, they've brought fresh perspectives to our organization and made a positive impact every day. Today, we’re celebrating the dedication and hard work of Rachel Caren, Christopher Schafer & Yashwin Madakamutil! Thank you for all that you do!

For #FeatureFriday this week, we are happy to introduce David Vigil. Aside from his work on our engineering team, David has also been our photographer - he took the action shot we shared for our recent feature on his colleague Scott Sylliaasen. David shared that his motto or 'words to live by' is "Only those who dare to fail greatly can ever achieve greatly." He is in good company at Pleno where we take on great challenges in our quest to create a disruptive technology and we do it with a spirit of collaboration and positivity as David highlights. #plenopeople #engineering #engineers #innovation #collaboration #multiomics

It's #FeatureFriday! Today we are featuring and welcoming our newest Pleno team members!  Morassa Mohseni, PhD 🧬, Marc Montserrat, Michael John Erickstad, Brenndon Lee & Richard Kelley, join us in our mission to design, develop and bring to market a revolutionary instrument platform that transforms methods of multi-omic target detection for a range of impactful applications. Visit our website to learn more about our RAPTOR instrument. To quote our CEO and founder, Pieter van Rooyen, “It is a true testament to our incredible team that has not only reimagined genomic testing, but also made it a reality in record time.” https://lnkd.in/g32fSndD #plenopeople #innovators #engineers #scientists #multiomics